To date, 18 living recommendations for the clinical care of pregnant and postpartum women
with COVID‐19 have been issued by the National COVID‐19 Clinical Evidence Taskforce …

Background The spread of the novel coronavirus (COVID-19) was declared a pandemic by
the World Health Organization on 11th March 2020. Since then there has been a rapid rise …

Abstract Introduction The Australian National COVID‐19 Clinical Evidence Taskforce was
established in March 2020 to maintain up‐to‐date recommendations for the treatment of …

Introduction Rapid, robust and continually updated evidence synthesis is required to inform
management of COVID-19 in pregnant and postpartum women and to keep pace with the …

Background Nearly a year after COVID‐19 was initially detected, guidance for pregnant and
new mothers remains varied. Objective The goal of this systematic review is to summarize …

Pregnant women seem to be at risk for developing complications from COVID-19. Given the
limited knowledge about the impact of COVID-19 on pregnancy, management guidelines …

These guidelines follow the mission of the World Association of Perinatal Medicine, which
brings together groups and individuals throughout the world with the goal of improving …

Objective Clinical trials evaluating pharmacological and non-pharmacological treatment of
COVID-19, either excluded pregnant women or included very few women. Unlike the …

Introduction Evidence about coronavirus disease 2019 (COVID‐19) and pregnancy has
rapidly increased since December 2019, making it difficult to make rigorous evidence‐based …

Since the declaration of the global pandemic of COVID-19 by the World Health Organization
on 11 March 2020, we have continued to see a steady rise in the number of patients infected …